Clinical experience with two etanercept biosimilars in Indian patients with spondyloarthritis

Clinical experience with two etanercept biosimilars in Indian patients with spondyloarthritis

Background: Antitumor necrosis factor (TNF) drugs are highly efficacious in spondyloarthritis (SpA). We present retrospective analysis of our experience with 2 etanercept biosimilars (Etacept and Intacept). Methods: Clinical record of patients with axial and/or peripheral SpA (Assessment of SpA Inte...

Full description

Saved in:
Bibliographic Details
Main Authors: Ashok Kumar, Anshul Goel, Mehul Lapsiwala, Mohit Goyal, Gaurav Dembla
Format: Article
Language:English
Published: SAGE Publishing 2017-01-01
Series:Indian Journal of Rheumatology
Subjects:
Antitumor necrosis factor
biological
biosimilar
etanercept
spondyloarthritis
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=3;spage=139;epage=145;aulast=Kumar
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=3;spage=139;epage=145;aulast=Kumar

Similar Items